Skip to main content

Advertisement

Log in

In silico study of peptide inhibitors against BACE 1

  • Research Article
  • Published:
Systems and Synthetic Biology

Abstract

Peptides are increasingly used as inhibitors of various disease specific targets. Several naturally occurring and synthetically developed peptides are undergoing clinical trials. Our work explores the possibility of reusing the non-expressing DNA sequences to predict potential drug-target specific peptides. Recently, we experimentally demonstrated the artificial synthesis of novel proteins from non-coding regions of Escherichia coli genome. In this study, a library of synthetic peptides (Synpeps) was constructed from 2500 intergenic E. coli sequences and screened against Beta-secretase 1 protein, a known drug target for Alzheimer’s disease (AD). Secondary and tertiary protein structure predictions followed by protein–protein docking studies were performed to identify the most promising enzyme inhibitors. Interacting residues and favorable binding poses of lead peptide inhibitors were studied. Though initial results are encouraging, experimental validation is required in future to develop efficient target specific inhibitors against AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Ahrens VM, Bellmann-Sickert K, Beck-Sickinger AG (2012) Peptides and peptide conjugates: therapeutics on the upward path. Future Med Chem 4(12):1567–1586

    Article  CAS  PubMed  Google Scholar 

  • Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403–410

    Article  CAS  PubMed  Google Scholar 

  • Avan I, Hall CD, Katritzky AR (2014) Peptidomimetics via modifications of amino acids and peptide bonds. Chem Soc Rev 43(10):3575–3594

    Article  CAS  PubMed  Google Scholar 

  • Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489(7414):57–74

    Article  Google Scholar 

  • Blattner FR, Plunkett G, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y (1997) The complete genome sequence of Escherichia coli K-12. Science 277(5331):1453–1462

    Article  CAS  PubMed  Google Scholar 

  • Brookmeyer R, Gray S, Kawas C (1998) Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am J Public Health 88(9):1337–1342

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement 3(3):186–191

    Article  PubMed  Google Scholar 

  • Craik DJ, Fairlie DP, Liras S, Price D (2013) The future of peptide-based drugs. Chem Biol Drug Des 81(1):136–147

    Article  CAS  PubMed  Google Scholar 

  • De Castro E, Sigrist CJ, Gattiker A, Bulliard V, Langendijk-Genevaux PS, Gasteiger E, Bairoch A, Hulo N (2006) ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins. Nucl Acids Res 34:362–365

    Article  Google Scholar 

  • Dhar PK, Thwin CS, Tun K, Tsumoto Y, Maurer-Stroh S, Eisenhaber F, Surana U (2009) Synthesizing non-natural parts from natural genomic template. J Biol Eng 3:2

    Article  PubMed Central  PubMed  Google Scholar 

  • Dinger ME, Pang KC, Mercer TR, Mattick JS (2008) Differentiating protein-coding and non coding RNA: challenges and ambiguities. PLoS Comput Biol 4(11):e1000176

    Article  PubMed Central  PubMed  Google Scholar 

  • Dundas J, Ouyang Z, Tseng J, Binkowski A, Turpaz Y, Liang J (2006) CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucl Acids Res 34:116–118

    Article  Google Scholar 

  • Dutot L, Lecorche P, Burlina F, Marquant R, Point V, Sagan S, Chassaing G, Mallet JM, Lavielle S (2009) Glycosylated cell-penetrating peptides and their conjugates to a proapoptotic peptide: preparation by click chemistry and cell viability studies. J Chem Biol 3:51–65

    Article  PubMed Central  PubMed  Google Scholar 

  • Falciani C, Lozzi L, Pini A, Bracci L (2005) Bioactive peptides from libraries. Chem Biol 12(4):417–426

    Article  CAS  PubMed  Google Scholar 

  • Fernández-Llamazares AI, Adan J, Mitjans F, Spengler J, Albericio F (2014) Tackling lipophilicity of peptide drugs: replacement of the backbone N-methyl group of Cilengitide by N-oligoethylene glycol (N-OEG) chains. Bioconjug Chem 25(1):11–17

    Article  PubMed  Google Scholar 

  • Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A (2003) ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucl Acids Res 31:3784–3788

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A (2005) Protein identification and analysis tools on the ExPASy server. In: Walker JM (ed) The proteomics protocols handbook. Humana Press, New York, pp 571–607

    Chapter  Google Scholar 

  • Gauthier MA, Klok HA (2008) Peptide/protein-polymer conjugates: synthetic strategies and design concepts. Chem Commun (Camb) 21(23):2591–2611

    Article  Google Scholar 

  • Geldenhuys WJ, Van der Schyf CJ (2013) Rationally designed multi-targeted agents against neurodegenerative diseases. Curr Med Chem 20(13):1662–1672

    Article  CAS  PubMed  Google Scholar 

  • Gentilucci L, De Marco R, Cerisoli L (2010) Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. Curr Pharm Des 16(28):3185–3203

    Article  CAS  PubMed  Google Scholar 

  • Gui J, Liu B, Cao G, Lipchik AM, Perez M, Dekan Z, Mobli M, Daly NL, Alewood PF, Parker LL, King GF, Zhou Y, Jordt SE, Nitabach MN (2014) A tarantula-venom peptide antagonizes the TRPA1 nociceptor ion channel by binding to the S1–S4 gating domain. Curr Biol 24(5):473–483

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Hamada Y, Ishiura S, Kiso Y (2012) BACE1 inhibitor peptides: can an infinitely small kcat value turn the substrate of an Enzyme into its inhibitor? ACS Med Chem Lett 3(3):193–197

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Han TS, Teichert RW, Olivera BM, Bulaj G (2008) Conus venoms—a rich source of peptide-based therapeutics. Curr Pharm Des 14(24):2462–2479

    Article  CAS  PubMed  Google Scholar 

  • Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256(5054):184–185

    Article  CAS  PubMed  Google Scholar 

  • Hong L, Koelsch G, Lin X, Wu S, Terzyan S, Ghosh AK, Zhang XC, Tang J (2000) Structure of the protease domain of memapsin 2 (β-Secretase) complexed with inhibitor. Science 290(5489):150–153

    Article  CAS  PubMed  Google Scholar 

  • Hruby VJ, Cai M (2013) Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles. Annu Rev Pharmacol Toxicol 53:557–580

    Article  CAS  PubMed  Google Scholar 

  • Joshi M, Shankar VK, Poovaiah T, Ingle K, Dhar PK (2013) Discovering novel anti-malarial peptides from the not-coding genome—a working hypothesis. Curr Synth Syst Biol 1:103

    Google Scholar 

  • Kageyama Y, Kondo T, Hashimoto Y (2011) Coding vs non-coding: translatability of short ORFs found in putative non-coding transcripts. Biochimie 93:1981–1986

    Article  CAS  PubMed  Google Scholar 

  • Kaspar AA, Reichert JM (2013) Future directions for peptide therapeutics development. Drug Discov Today 18(17–18):807–817

    Article  CAS  PubMed  Google Scholar 

  • Lahiri DK, Farlow MR, Greig NH, Sambamurti K (2002) Current drug targets for Alzheimer’s disease treatment. Drug Dev Res 56:267–281

    Article  CAS  Google Scholar 

  • Li H, Aneja R, Chaiken I (2013) Click chemistry in peptide-based drug design. Molecules 18:9797–9817

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Long JM, Lahiri DK (2011) Current drug targets for modulating Alzheimer’s amyloid precursor protein: role of specific micro-RNA species. Curr Med Chem 18(22):3314–3321

    Article  CAS  PubMed  Google Scholar 

  • Lorber D (2013) GLP-1 receptor agonists: effects on cardiovascular risk reduction. Cardiovasc Ther 31(4):238–249

    Article  CAS  PubMed  Google Scholar 

  • Mashiach E, Schneidman-Duhovny D, Andrusier N, Nussinov R, Wolfson HJ (2008) FireDock: a web server for fast interaction refinement in molecular docking. Nucl Acids Res 36:229–232

    Article  Google Scholar 

  • Mason JM (2010) Design and development of peptides and peptide mimetics as antagonists for therapeutic intervention. Future Med Chem 2(12):1813–1822

    Article  CAS  PubMed  Google Scholar 

  • Meloen R, Timmerman P, Langedijk H (2004) Bioactive peptides based on diversity libraries, supramolecular chemistry and rational design: a new class of peptide drugs. Introduction. Mol Divers 8(2):57–59

    Article  CAS  PubMed  Google Scholar 

  • Menschaert G, Vandekerckhove TT, Baggerman G, Schoofs L, Luyten W, Van Criekinge W (2010) Peptidomics coming of age: a review of contributions from a bioinformatics angle. J Proteome Res 9(5):2051–2061

    Article  CAS  PubMed  Google Scholar 

  • Merrifield RB (1963) Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J Am Chem Soc 85(14):2149–2154

    Article  CAS  Google Scholar 

  • Niu Y, Gao H, Xu F, Wang C, Liu P, Yang G, Sun Q, Xu P (2012) Synthesis, in vitro biological evaluation and molecular docking studies of benzimidamides as potential BACE1 inhibitors. Chem Biol Drug Des 80(5):775–780

    Article  CAS  PubMed  Google Scholar 

  • Pandey R, Singh AV, Pandey A, Tripathi P, Majumdar SK, Nath LK (2009) Protein and peptide drugs: a brief review. Res J Pharm Tech 2(2):228–233

    Google Scholar 

  • Pinelli NR, Hurren KM (2011) Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared with exenatide twice daily and sitagliptin in type 2 diabetes mellitus: a systematic review and meta-analysis. Ann Pharmacother 45(7–8):850–860

    Article  CAS  PubMed  Google Scholar 

  • Raghavan R, Groisman EA, Ochman H (2011) Genome-wide detection of novel regulatory RNAs in E. coli. Genome Res 21(9):1487–1497

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Rodríguez AA, Salceda E, Garateix AG, Zaharenko AJ, Peigneur S, López O, Pons T, Richardson M, Díaz M, Hernández Y, Ständker L, Tytgat J, Soto E (2014) A novel sea anemone peptide that inhibits acid-sensing ion channels. Peptides 53:3–12

    Article  PubMed  Google Scholar 

  • Saez NJ, Senff S, Jensen JE, Er SY, Herzig V, Rash LD, King GF (2010) Spider-venom peptides as therapeutics. Toxins (Basel) 2(12):2851–2871

    Article  CAS  Google Scholar 

  • Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ (2005) PatchDock and SymmDock: servers for rigid and symmetric docking. Nucl Acids Res 33:363–367

    Article  Google Scholar 

  • Sciarretta KL, Gordon DJ, Meredith SC (2006) Peptide-based inhibitors of amyloid assembly. Methods Enzymol 413:273–312

    Article  CAS  PubMed  Google Scholar 

  • Shidhi PR, Nair AS, Suravajhala P (2014) Identifying pseudogenes from hypothetical proteins for making synthetic proteins. Syst Synth Biol 8(2):169–171

    Article  CAS  PubMed  Google Scholar 

  • Speck-Planche A, Kleandrova VV, Luan F, Cordeiro MN (2013) Multi-target inhibitors for proteins associated with Alzheimer: in silico discovery using fragment-based descriptors. Curr Alzheimer Res 10(2):117–124

    Article  CAS  PubMed  Google Scholar 

  • Strub JM, Goumon Y, Lugardon K, Capon C, Lopez M, Moniatte M, Van Dorsselaer A, Aunis D, Metz-Boutigue MH (1996) Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173–194 from bovine adrenal medullary chromaffin granules. J Biol Chem 271(45):28533–28540

    Article  CAS  PubMed  Google Scholar 

  • Thundimadathil J (2012) Cancer treatment using peptides: current therapies and future prospects. J Amino Acids 2012:1–13. doi:10.1155/2012/967347

    Article  Google Scholar 

  • Venter JC, Adams MD, Myers EW et al (2001) The sequence of the human genome. Science 291(5507):1304–1351

    Article  CAS  PubMed  Google Scholar 

  • Verdine GL, Hilinski GJ (2012) Stapled peptides for intracellular drug targets. Methods Enzymol 503:3–33

    Article  CAS  PubMed  Google Scholar 

  • Viayna E, Sabate R, Muñoz-Torrero D (2013) Dual inhibitors of β-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidates. Curr Top Med Chem 13(15):1820–1842

    Article  CAS  PubMed  Google Scholar 

  • Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M (2010) Synthetic therapeutic peptides: science and market. Drug Discov Today 15(1–2):40–56

    Article  CAS  PubMed  Google Scholar 

  • Wang Q, Yu X, Li L, Zheng J (2014) Inhibition of amyloid-β aggregation in Alzheimer’s disease. Curr Pharm Des 20(8):1223–1243

    Article  CAS  PubMed  Google Scholar 

  • Xu Y, Li MJ, Greenblatt H, Chen W, Paz A, Dym O, Peleg Y, Chen T, Shen X, He J, Jiang H, Silman I, Sussman JL (2012) Flexibility of the flap in the active site of BACE1 as revealed by crystal structures and molecular dynamics simulations. Acta Crystallogr D Biol Crystallogr 68(1):13–25

    Article  CAS  PubMed  Google Scholar 

  • Yan R, Vassar R (2014) Targeting the β secretase BACE1 for Alzheimer’s disease therapy. Lancet Neurol 13(3):319–329

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Yeon SW, Jeon YJ, Hwang EM, Kim TY (2007) Effects of peptides derived from BACE1 catalytic domain on APP processing. Peptides 28(4):838–844

    Article  CAS  PubMed  Google Scholar 

  • Zhang Y (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinform 9:40

    Article  Google Scholar 

  • Zhao L, Saelao P, Jones CD, Begun DJ (2014) Origin and spread of de novo genes in Drosophila melanogaster populations. Science 343(6172):769–772

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We sincerely thank the State Inter-University Centre of Excellence in Bioinformatics (SIUCEB), University of Kerala for the funding provided during this work.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pawan K. Dhar.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Raj, N., Helen, A., Manoj, N. et al. In silico study of peptide inhibitors against BACE 1. Syst Synth Biol 9, 67–72 (2015). https://doi.org/10.1007/s11693-015-9169-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11693-015-9169-7

Keywords

Navigation